Skip to main content
Clinical Trials/NCT02507245
NCT02507245
Completed
Not Applicable

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD): Lung Function Parameters Assessment; Quality of Life Assessment; Stress Parenting Assessment (Pneumo GHD)

Stefania La Grutta, MD0 sites48 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Growth Hormone-Releasing Hormone
Conditions
Growth Hormone Deficiency
Sponsor
Stefania La Grutta, MD
Enrollment
48
Primary Endpoint
Assessment of the developmental patterns of lung function before and after GH by spirometry
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this study is to assess the developmental patterns of lung function in children affected by growth hormone deficiency after one year of GH therapy.The assessment by specific questionnaires of quality of life and of parental stress index.Parameters will be evaluated at the time of the diagnosis and after 12 months of GH therapy.

Detailed Description

Observational longitudinal study in children affected by idiopathic growth hormone deficiency (GHD): lung function parameters assessment; quality of life assessment; stress parenting assessment (Pneumo GHD). The aim of this study is to assess the developmental patterns of lung function in children affected by growth hormone deficiency after one year of GH therapy.The assessment by specific questionnaires of quality of life and of parental stress index.Parameters will be evaluated at the time of the diagnosis and after 12 months of GH therapy.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
May 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Stefania La Grutta, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Stefania La Grutta, MD

Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.

Istituto per la Ricerca e l'Innovazione Biomedica

Eligibility Criteria

Inclusion Criteria

  • GH deficiency

Exclusion Criteria

  • Respiratory infections 4 weeks before the recruitment
  • Children with autoimmune diseases
  • Therapy with drugs able to modify the lung function

Arms & Interventions

GHD Children

Treatment with Growth Hormone-Releasing Hormone in children affected by idiopathic growth hormone deficiency (GHD)

Intervention: Growth Hormone-Releasing Hormone

Outcomes

Primary Outcomes

Assessment of the developmental patterns of lung function before and after GH by spirometry

Time Frame: 1 year

Assessment of lung function before and after administration of GH in children with growth hormone deficiency by spirometry

Similar Trials